Skip to main content
. 2018 Aug 2;18:25. doi: 10.1186/s40644-018-0158-4

Fig. 2.

Fig. 2

Flow chart of the study protocol. The trial consisted of two phases: in phase 1 accuracy of 11C-acetate PET/MRI was evaluated on 15 treatment naive patients before any intervention of primary tumor. In phase 2 treatment response to Neoadjuvant chemotherapy (NAC) was evaluated in 5 patients undergoing 11C-acetate PET/MRI after transurethral resection of bladder tumor (TUR-BT) and neoadjuvant chemotherapy. 2 patients participated in both phases of the study. In total, 18 patients were enrolled